Advertisement

Non-invasive Measurement of Portal Pressure

  • Ahmed M. Elmahdy
  • Annalisa BerzigottiEmail author
Management of Cirrhotic Patient (A Cardenas and P Tandon, Section Editors)
  • 41 Downloads
Part of the following topical collections:
  1. Topical Collection on Management of the Cirrhotic Patient

Abstract

Purpose of Review

To provide an updated overview of the existing and emerging non-invasive diagnostic methods to assess portal hypertension.

Recent Findings

Data on liver stiffness measurement confirmed that it is a mainstay for assessing the risk of clinically significant portal hypertension in patients with advanced chronic liver disease of any etiology. The Baveno criteria for identifying patients who can safely spare endoscopy have been validated in NASH and cholestatic liver disease. New expanded criteria and other simple non-invasive algorithms including MELD score or spleen stiffness have been proposed and can lead to a higher proportion of endoscopies without significantly increasing the risk of missing large esophageal varices. MR and CT improve the anatomical imaging of gastroesophageal varices and abdominal collaterals and dynamic imaging based on MR and able to quantify hepatic blood flow are in development. Contrast-enhanced ultrasound and methacetin breath test are emerging promising methods to estimate the HVPG non-invasively.

Summary

Several different non-invasive methods are now available and can be used in clinical practice to achieve a successful identification of patients with clinically significant portal hypertension in chronic liver disease. However, an exact estimation of HVPG is not available yet, and changes in portal pressure cannot yet be detected by non-invasive methods.

Keywords

Liver cirrhosis Ultrasound Elastography Magnetic resonance CEUS 

Notes

Compliance with Ethical Standards

Conflict of Interest

Ahmed M.Elmahdy and Annalisa Berzigotti each declare no potential conflicts of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    •• Garcia-Tsao G, Abraldes JG, Berzigotti A, Bosch J. Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases. Hepatology. 2017;65(1):310–35 Practical evidence-based guidance on the modern management of portal hypertension. CrossRefGoogle Scholar
  2. 2.
    Berzigotti A, Seijo S, Reverter E, Bosch J. Assessing portal hypertension in liver diseases. Expert Rev Gastroenterol Hepatol. 2013;7(2):141–55.CrossRefGoogle Scholar
  3. 3.
    Bosch J. Vascular deterioration in cirrhosis: the big picture. J Clin Gastroenterol. 2007;41(Suppl 3):S247–53.CrossRefGoogle Scholar
  4. 4.
    Berzigotti A, Bosch J. Pharmacologic management of portal hypertension. Clin Liver Dis. 2014;18(2):303–17.CrossRefGoogle Scholar
  5. 5.
    •• de Franchis R, Baveno VI. Faculty. Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension. J Hepatol. 2015;63(3):743–52 Summary of the most recent international consensus conference on portal hypertension. CrossRefGoogle Scholar
  6. 6.
    D'Amico G, Garcia-Pagan JC, Luca A, Bosch J. Hepatic vein pressure gradient reduction and prevention of variceal bleeding in cirrhosis: a systematic review. Gastroenterology. 2006;131(5):1611–24.CrossRefGoogle Scholar
  7. 7.
    Procopet B, Berzigotti A. Diagnosis of cirrhosis and portal hypertension: imaging, non-invasive markers of fibrosis and liver biopsy. Gastroenterol Rep. 2017;5(2):79–89.CrossRefGoogle Scholar
  8. 8.
    Thiele M, Madsen BS, Procopet B, Hansen JF, Moller LM, Detlefsen S, et al. Reliability criteria for liver stiffness measurements with real-time 2D shear wave elastography in different clinical scenarios of chronic liver disease. Ultraschall Med 2017;38(6):648–654.Google Scholar
  9. 9.
    Berzigotti A, Piscaglia F. Ultrasound in portal hypertension--part 1. Ultraschall Med. 2011;32(6):548–68 quiz 69-71.CrossRefGoogle Scholar
  10. 10.
    Berzigotti A, Piscaglia F, Education E, Professional Standards C. Ultrasound in portal hypertension--part 2--and EFSUMB recommendations for the performance and reporting of ultrasound examinations in portal hypertension. Ultraschall Med. 2012;33(1):8–32 quiz 0-1.CrossRefGoogle Scholar
  11. 11.
    Schepis F, Camma C, Niceforo D, Magnano A, Pallio S, Cinquegrani M, et al. Which patients with cirrhosis should undergo endoscopic screening for esophageal varices detection? Hepatology. 2001;33(2):333–8.CrossRefGoogle Scholar
  12. 12.
    Abraldes JG, Gilabert R, Turnes J, Nicolau C, Berzigotti A, Aponte J, et al. Utility of color Doppler ultrasonography predicting tips dysfunction. Am J Gastroenterol. 2005;100(12):2696–701.CrossRefGoogle Scholar
  13. 13.
    • Dietrich CF, Bamber J, Berzigotti A, Bota S, Cantisani V, Castera L, et al. EFSUMB guidelines and recommendations on the clinical use of liver ultrasound elastography, Update 2017 (Long Version). Ultraschall Med. 2017;38(4):e48 Updated guidelines on the use of elastography in liver disease. CrossRefGoogle Scholar
  14. 14.
    • Berzigotti A. Non-invasive evaluation of portal hypertension using ultrasound elastography. J Hepatol. 2017;67(2):399–411 Updated summary on the use of elastography for portal hypertension. CrossRefGoogle Scholar
  15. 15.
    Vizzutti F, Arena U, Romanelli RG, Rega L, Foschi M, Colagrande S, et al. Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis. Hepatology. 2007;45(5):1290–7.CrossRefGoogle Scholar
  16. 16.
    Shi KQ, Fan YC, Pan ZZ, Lin XF, Liu WY, Chen YP, et al. Transient elastography: a meta-analysis of diagnostic accuracy in evaluation of portal hypertension in chronic liver disease. Liver Int. 2013;33(1):62–71.CrossRefGoogle Scholar
  17. 17.
    Berzigotti A, Seijo S, Arena U, Abraldes JG, Vizzutti F, Garcia-Pagan JC, et al. Elastography, spleen size, and platelet count identify portal hypertension in patients with compensated cirrhosis. Gastroenterology. 2013;144(1):102–11 e1.CrossRefGoogle Scholar
  18. 18.
    • Petta S, Sebastiani G, Bugianesi E, Vigano M, Wong VW, Berzigotti A, et al. Noninvasive prediction of esophageal varices by stiffness and platelet in nonalcoholic fatty liver disease cirrhosis. Journal of hepatology. J Hepatol. 2018;69(4):878–85 First validation of the Baveno non-invasive criteria for avoiding endoscopy in patients with NASH. CrossRefGoogle Scholar
  19. 19.
    • Moctezuma-Velázquez C, Saffioti F, Tasayco-Huamán S, Casu S, Mason A, Roccarina D.V, et al. Non-invasive prediction of high-risk varices in patients with primary biliary cholangitis and primary sclerosing cholangitis. Am J Gastroenterol 2018.  https://doi.org/10.1038/s41395-018-0265-7 First validation of the Baveno non-invasive criteria for avoiding endoscopy in patients with cholestatic liver disease.
  20. 20.
    Bae J, Sinn DH, Kang W, Gwak GY, Choi MS, Paik YH, et al. Validation of the Baveno VI and the expanded Baveno VI criteria to identify patients who could avoid screening endoscopy. Liver Int. 2018;38(8):1442–8.CrossRefGoogle Scholar
  21. 21.
    Augustin S, Pons M, Maurice JB, Bureau C, Stefanescu H, Ney M, et al. Expanding the Baveno VI criteria for the screening of varices in patients with compensated advanced chronic liver disease. Hepatology. 2017;66(6):1980–8.CrossRefGoogle Scholar
  22. 22.
    Colecchia A, Ravaioli F, Marasco G, Colli A, Dajti E, Di Biase AR, et al. A combined model based on spleen stiffness measurement and Baveno VI criteria to rule out high-risk varices in advanced chronic liver disease. J Hepatol. 2018;69(2):308–17.CrossRefGoogle Scholar
  23. 23.
    Robic MA, Procopet B, Metivier S, Peron JM, Selves J, Vinel JP, et al. Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: a prospective study. J Hepatol. 2011;55(5):1017–24.CrossRefGoogle Scholar
  24. 24.
    Margini C, Murgia G, Stirnimann G, De Gottardi A, Semmo N, Casu S, et al. Prognostic significance of controlled attenuation parameter in patients with compensated advanced chronic liver disease. Hepatol Commun. 2018;2(8):929–40.CrossRefGoogle Scholar
  25. 25.
    •• Lens S, Alvarado-Tapias E, Marino Z, Londono MC, LL E, Martinez J, et al. Effects of all-Oral anti-viral therapy on HVPG and systemic hemodynamics in patients with hepatitis C virus-associated cirrhosis. Gastroenterology. 2017;153(5):1273–83 e1 Detailed description of portal pressure changes after modern antiviral therapy of HCV. CrossRefGoogle Scholar
  26. 26.
    Jansen C, Moller P, Meyer C, Kolbe CC, Bogs C, Pohlmann A, et al. Increase in liver stiffness after transjugular intrahepatic portosystemic shunt is associated with inflammation and predicts mortality. Hepatology. 2018;67(4):1472–84.CrossRefGoogle Scholar
  27. 27.
    Sharma P, Mishra SR, Kumar M, Sharma BC, Sarin SK. Liver and spleen stiffness in patients with extrahepatic portal vein obstruction. Radiology. 2012;263(3):893–9.CrossRefGoogle Scholar
  28. 28.
    Deng H, Qi X, Guo X. Computed tomography for the diagnosis of varices in liver cirrhosis: a systematic review and meta-analysis of observational studies. Postgrad Med. 2017;129(3):318–28.CrossRefGoogle Scholar
  29. 29.
    Simon-Talero M, Roccarina D, Martinez J, Lampichler K, Baiges A, Low G, et al. Association between portosystemic shunts and increased complications and mortality in patients with cirrhosis. Gastroenterology. 2018;154(6):1694–705 e4.CrossRefGoogle Scholar
  30. 30.
    Berzigotti A, Rossi V, Tiani C, Pierpaoli L, Zappoli P, Riili A, et al. Prognostic value of a single HVPG measurement and Doppler-ultrasound evaluation in patients with cirrhosis and portal hypertension. J Gastroenterol. 2011;46(5):687–95.CrossRefGoogle Scholar
  31. 31.
    Rohan E, Lukes V, Jonasova A. Modeling of the contrast-enhanced perfusion test in liver based on the multi-compartment flow in porous media. J Math Biol. 2018;77(2):421–54.CrossRefGoogle Scholar
  32. 32.
    Kihira S, Kagen AC, Vasudevan P, Jajamovich GH, Schiano TD, Andrle AF, et al. Non-invasive prediction of portal pressures using CT and MRI in chronic liver disease. Abdom Radiol. 2016;41(1):42–9.CrossRefGoogle Scholar
  33. 33.
    Wagner M, Hectors S, Bane O, Gordic S, Kennedy P, Besa C, et al. Noninvasive prediction of portal pressure with MR elastography and DCE-MRI of the liver and spleen: preliminary results. J Magn Reson Imaging: JMRI. 2018;48(4):1091–1103.Google Scholar
  34. 34.
    • Palaniyappan N, Cox E, Bradley C, Scott R, Austin A, O'Neill R, et al. Non-invasive assessment of portal hypertension using quantitative magnetic resonance imaging. J Hepatol. 2016;65(6):1131–9 Proof of concept study showing the potential of quantitative MRI to assess portal pressure. CrossRefGoogle Scholar
  35. 35.
    Claudon M, Dietrich CF, Choi BI, Cosgrove DO, Kudo M, Nolsoe CP, et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver--update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS. Ultraschall Med. 2013;34(1):11–29.Google Scholar
  36. 36.
    Kim MY, Suk KT, Baik SK, Kim HA, Kim YJ, Cha SH, et al. Hepatic vein arrival time as assessed by contrast-enhanced ultrasonography is useful for the assessment of portal hypertension in compensated cirrhosis. Hepatology. 2012;56(3):1053–62.CrossRefGoogle Scholar
  37. 37.
    Berzigotti A, Nicolau C, Bellot P, Abraldes JG, Gilabert R, Garcia-Pagan JC, et al. Evaluation of regional hepatic perfusion (RHP) by contrast-enhanced ultrasound in patients with cirrhosis. J Hepatol. 2011;55(2):307–14.CrossRefGoogle Scholar
  38. 38.
    Amat-Roldan I, Berzigotti A, Gilabert R, Bosch J. Assessment of hepatic vascular network connectivity with automated graph analysis of dynamic contrast-enhanced US to evaluate portal hypertension in patients with cirrhosis: a pilot study. Radiology. 2015;277(1):268–76.CrossRefGoogle Scholar
  39. 39.
    Halldorsdottir VG, Dave JK, Leodore LM, Eisenbrey JR, Park S, Hall AL, et al. Subharmonic contrast microbubble signals for noninvasive pressure estimation under static and dynamic flow conditions. Ultrason Imaging. 2011;33(3):153–64.CrossRefGoogle Scholar
  40. 40.
    Eisenbrey JR, Dave JK, Halldorsdottir VG, Merton DA, Miller C, Gonzalez JM, et al. Chronic liver disease: noninvasive subharmonic aided pressure estimation of hepatic venous pressure gradient. Radiology. 2013;268(2):581–8.CrossRefGoogle Scholar
  41. 41.
    Stravitz RT, Reuben A, Mizrahi M, Lalazar G, Brown K, Gordon SC, et al. Use of the methacetin breath test to classify the risk of cirrhotic complications and mortality in patients evaluated/listed for liver transplantation. J Hepatol. 2015;63(6):1345–51.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Mansoura Faculty of MedicineMansouraEgypt
  2. 2.Hepatology, University Clinic for Visceral Surgery and Medicine, InselspitalUniversity of BernBernSwitzerland

Personalised recommendations